Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study

Raherison C, Girodet PO: Epidemiology of COPD. Eur Respir Rev. 2009, 18: 213-221. 10.1183/09059180.00003609.

Lin HH, Murray M, Cohen T, Colijn C, Ezzati M: Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study. Lancet. 2008, 372 (9648): 1473-1483. 10.1016/S0140-6736(08)61345-8.

Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W, MacDonald R, Shekelle P: Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011, 155 (3): 179-191.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: Satmeterol and flutieasene propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007, 356 (8): 775-789. 10.1056/NEJMoa063070.

Li JS, Wang ZW, Yu XQ, Wang MH, Li SY: Clinical efficacy and safety of TCM for COPD at stable phase: A Systematic review. Liaoning Zhong Yi Za Zhi. 2010, 37 (2): 229-232.

Li JS, Wang ZW, Yu XQ, Wang MH, Li SY: Systemic evaluation of TCM for COPD in the acute stage of exacerbation. Tianjin Zhong Yi Yao. 2008, 25 (5): 428-431.

Zhang WJ, Zhang YP: Recent research in chronic obstructive pulmonary disease treated with TCM. Beijing Zhong Yi Yao Da Xue Xue Bao (Clinical Medicine). 2007, 14 (5): 39-41.

Lu AP, Chen KJ: Chinese medicine pattern diagnosis could lead to innovation in medical sciences. Zhong Guo Zhong Xi Yi Jie He Za Zhi. 2011, 17 (11): 811-817.

Wang ZW, Li JS, Yu XQ, Wang MH, Li SY: Symptom diagnosis criteria for chronic obstructive pulmonary diseases at stationary phase from literature. Zhong Yi Yan Jiu. 2008, 21 (8): 55-58.

Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Revised 2006, http://goldcopd.com/index.2007-01-22 ,

COPD Study Group of Chinese Society of Respiratory Disease: Treatment guidelines of chronic obstructive pulmonary disease (revised 2007). Zhong Hua Jie He Yu Hu Xi Za Zhi. 2007, 30 (1): 8-17.

Li JS, Li SY, Wang ZW, Yu XQ, Wang MH, Wang YY, The internal medicine branch of China Association of Chinese Medicine: Syndrome diagnostic criteria of TCM of Chronic Obstructive Pulmonary Disease (2011 Edition). Zhong Yi Za Zhi. 2012, 53 (2): 177-178.

Hong ML, Chen WX, Cai SH, Gao LY, Dai SZ, Chen ZB: The interventional effects of yufeining on lung function in patients with chronic obstructive pulmonary disease. Zhong Hua Zhong Yi Yao Za Zhi. 2005, 20 (2): 92-95.

Celli BR, MacNee W: Standards for the diagnosis and treatment of patients with COPD: a summary the ATS/ERS position paper. Eur Respir J. 2004, 23 (6): 932-946. 10.1183/09031936.04.00014304.

Jamieson S: Likert scales: how to (ab)use them. Med Educ. 2004, 38 (12): 1217-1218. 10.1111/j.1365-2929.2004.02012.x.

ATS: ATS statement: guidelines for the Six-minute walk test. Am J Respir Crit Care Med. 2002, 166: 111-117.

Fletcher CM, Elmes PC, Fairbairn MB, Wood CH: The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959, 2 (5147): 257-266. 10.1136/bmj.2.5147.257.

Mahler DA, Well CK: Evaluation of clinical methods for rating dyspnea. Chest. 1988, 93 (3): 580-586. 10.1378/chest.93.3.580.

WHO: The world health organization quality of life (WHOQOL-BREF). 2004, Geneva: World Health Organization

Bourbeau J, Ford G, Zackon H, Pinsky N, Lee J, Ruberto G: Impact on patients' health status following early identification of a COPD exacerbation. Eur Respir J. 2007, 30 (5): 907-913. 10.1183/09031936.00166606.

Burge S, Wedzicha JA: COPD exacerbations: definitions and classifications. Eur Respir J. 2003, 21 (41): 46-53. 10.1183/09031936.03.00078002.

Wedzicha JA, Seemungal TA: COPD exacerbations: defining their cause and prevention. Lancet. 2007, 370 (9589): 786-796. 10.1016/S0140-6736(07)61382-8.

Li JS, Wang MH: The clinical significance of acute exacerbation of chronic obstructive pulmonary disease. Zhong Guo Wei Zhong Bing Ji Jiu Yi Xue. 2007, 19 (9): 572-573.

Lung Health Study Research Group: Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med. 2000, 343 (26): 1902-1909.

Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M: A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008, 359 (15): 1543-1554. 10.1056/NEJMoa0805800.

Li JS, Li SY, Wang MH: Appraisal investigating progression of chronic obstructive pulmonary dyspnea. Henan Zhong Yi Xue Yuan Xue Bao. 2007, 22 (129): 79-80.

Camargo LA, Pereira CA: Dyspnea in COPD: beyond the modified medical research council scale. J Bras Pneumol. 2010, 36 (5): 571-578.

Morales-Blanhir JE, Palafox Vidal CD, Rosas Romero Mde J, García Castro MM, Londoño Villegas A, Zamboni M: Six-minute walk test: a valuable tool for assessing pulmonary impairment. J Bras Pneumol. 2011, 37 (1): 110-117. 10.1590/S1806-37132011000100016.

Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004, 350 (10): 1005-1012. 10.1056/NEJMoa021322.

Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF: Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010, 91 (2): 221-225. 10.1016/j.apmr.2009.10.017.

Li JS, Li SY, Wang MH: Functional status and living quality change of chronic obstructive pulmonary diseases. Henan Zhong Yi Xue Yuan Xue Bao. 2007, 22 (1): 19-22.